Canntab Therapeutics Limited Reports Earnings Results for the Second Quarter Ended November 30, 2019
January 28, 2020 at 11:48 am EST
Canntab Therapeutics Limited announced earnings results for the second quarter ended November 30, 2019. For the second quarter, the company announced operating loss was CAD 625,510 compared to CAD 797,334 a year ago. Net loss was CAD 623,102 compared to CAD 787,396 a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago. For the half year, operating loss was CAD 1.069 million compared to CAD 1.265 million a year ago. Net loss was CAD 1.062 million compared to CAD 1.234 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.05 a year ago.